• Explore /
  • Poster
  • / Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents.

Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents.

Abstract Video & Slides Poster

Authors

null

Sanjal Desai

University of Minnesota, Minneapolis, MN

Sanjal Desai , Michael Alexander Spinner , Kevin A. David , Veronika Bachanova , Gaurav Goyal , Raya Saba , Kathleen Anne Dorritie , Jacques Mario Azzi , Elyse Harris , Brendon Fusco , Nuttavut Sumransub , Haris Hatic , Uroosa Ibrahim , Siddharth Iyengar , Katherine Cynthia Rappazzo , Firas Baidoun , Victor Manuel Orellana-Noia , Catherine S. Magid Diefenbach , Ranjana H. Advani , Ivana N. M. Micallef

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Hodgkin Lymphoma

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7515)

DOI

10.1200/JCO.2022.40.16_suppl.7515

Abstract #

7515

Poster Bd #

169

Abstract Disclosures

Similar Posters

First Author: Paul David Harker-Murray

First Author: Peter D. Cole

First Author: David Lavie

First Author: Charlotte Burton Wagner